Sort   by:  
 Page size 
UnknownIndustry funding of patient and health consumer organisations: systematic review with meta-analysis.
Not available
S-EPMC7190040 | biostudies-literature
UnknownProducing an evidence-based treatment information website in partnership with people affected by multiple sclerosis.
Not available
S-EPMC6266475 | biostudies-literature
UnknownCirculating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC.
Not available
S-EPMC9530186 | biostudies-literature
UnknownPhase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial.
Not available
S-EPMC12226327 | biostudies-literature
UnknownEfficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice.
Not available
S-EPMC2909229 | biostudies-literature
UnknownEpiNet as a way of involving more physicians and patients in epilepsy research: Validation study and accreditation process.
Not available
S-EPMC5939455 | biostudies-literature
UnknownFasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer.
Not available
S-EPMC9762338 | biostudies-literature
UnknownINOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.
Not available
S-EPMC10070417 | biostudies-literature
UnknownIntraperitoneal drain placement and outcomes after elective colorectal surgery: international matched, prospective, cohort study.
Not available
S-EPMC10364732 | biostudies-literature
UnknownForecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
Not available
S-EPMC11447278 | biostudies-literature
Sort   by:  
 Page size